Coinciding with this year’s International Nurses Day, this week’s Federal Budget has had some significant outcomes for the primary health care, nursing workforce.
The Federal Budget delivered on 9th May 2023, APNA believes will strengthen Australia’s primary health care (PHC) system by addressing growing nursing shortages, seeing more nurses hired where they are needed, and better utilising the largest workforce in PHC of nearly 100,000 nurses to their full potential to reduce the pressure on the health system.
The Federal Budget could significantly boost job prospects and career progression in primary healthcare, as well as strengthen the current PHC nursing workforce by funding:
- An 18-month national Scope of Practice review
- 6,000 additional clinical placements in primary healthcare nursing ($4.2 million over four years)
- 1,850 graduate scholarships to train more Nurse Practitioners ($50.2 million over four years)
- $1 million towards incentives to get 500 nurses back into the workforce
Australian Health Journal met with APNA President Karen Booth and CEO Ken Griffin at their Money in May 2023 event in Sydney.
Money in May is an APNA member-only initiative and is a month of education so that nurses know more about money and how to navigate the financial side of being a nurse. The campaign has three key themes: do more, save more and earn more.
Timed to coincide with the end of the financial year, APNA has focused on financial literacy. Nurses who understand the opportunities and challenges of finance and funding mechanisms and keep abreast of changes can be an even greater asset for their patients and the business they work for. For their personal lives, they make better financial decisions, earn more and retire with more super.
The outcomes are for each Primary healthcare nurse in a time to influence and pitch for what they want — be that money to fund a nurse-led clinic, a financial allocation for CPD or negotiate pay.
Relating that back to the funding announcements in the Federal Budget, there is potential to significantly boost job prospects and career progression in primary healthcare, as well as strengthen the current PHC nursing workforce.
-
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy.
Australian Health Journal met with 3 speakers at the recent ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
-
Values in Workplace Culture
Professor Sabe Sabesan, is the Clinical Dean of the Townsville Regional Medical Training network incorporating the Townsville Hospital and Health Services and the Townsville Clinical School of the James Cook University and the director of the department of Medical oncology at the Townsville Cancer Centre, Townsville Hospital.
The Professor recently wrote, “Workforce wellness and engagement have become buzzwords in healthcare settings since there is an intimate relationship between staff wellbeing and performance of the healthcare system. Wellness initiatives such as wellness champions and wellness committees have been set up in response to emerging workforce mental health issues. These are largely reactive rather than being proactive in addressing or preventing the root cause of mental health issues.”
-
Continuing education program leads to better conversations
Medicines Australia’s Continuing Education Program (CEP) is designed to educate medical representatives to a recognised industry standard. Dr Tristan Ling, CEP Academic Lead and Project Manager at the College of Health and Medicine, University of Tasmania talks about the 900 students that come through the program each year.
The CEP is primarily directed at medical representatives working within the prescription medicines industry, but is also recommended to people who may not be currently employed within the industry but would like to pursue a career as a medical representative. It is also available to personnel working for organisations interacting with the pharmaceutical industry.
